microarray processing and analysis Search Results


microarray hybridisation and data normalisation analyses  (CapitalBio Corporation)
90
CapitalBio Corporation microarray hybridisation and data normalisation analyses
Microarray Hybridisation And Data Normalisation Analyses, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/microarray+hybridization+and+data+normalization+analysis/pmc03471800-67-4-10
Average 90 stars, based on 1 article reviews
microarray hybridisation and data normalisation analyses - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
mirna labeling, quality control, chip hybridization and microarray analysis  (CapitalBio Corporation)
90
CapitalBio Corporation mirna labeling, quality control, chip hybridization and microarray analysis
Mirna Labeling, Quality Control, Chip Hybridization And Microarray Analysis, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/mirna+labeling++quality+control++chip+hybridization+and+microarray+analysis/pmc05154343-155-17-5
Average 90 stars, based on 1 article reviews
mirna labeling, quality control, chip hybridization and microarray analysis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
microarray hybridization  (Genminix Informatics Co Ltd)
90
Genminix Informatics Co Ltd microarray hybridization
Microarray Hybridization, supplied by Genminix Informatics Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/microarray+hybridization+and+statistical+analysis/pm26690385-66-1-11
Average 90 stars, based on 1 article reviews
microarray hybridization - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
sample amplification, labeling, and microarray processing  (Rosetta Inpharmatics)
90
Rosetta Inpharmatics sample amplification, labeling, and microarray processing
Sample Amplification, Labeling, And Microarray Processing, supplied by Rosetta Inpharmatics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/sample+amplification++labeling++and+microarray+processing/pm20128659-78-5-11
Average 90 stars, based on 1 article reviews
sample amplification, labeling, and microarray processing - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
microarray analysis  (Wageningen University and Research)
90
Wageningen University and Research microarray analysis
Microarray Analysis, supplied by Wageningen University and Research, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/microarray+analysis/10__1074_slash_jbc__m109__040741-200-16-7
Average 90 stars, based on 1 article reviews
microarray analysis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
genetraffic bioinformatic software  (Iobion Informatics)
90
Iobion Informatics genetraffic bioinformatic software
Genetraffic Bioinformatic Software, supplied by Iobion Informatics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/genetraffic+microarray+database+and+analysis+system/10__1128_slash_mcb__01538___06-121-13-16
Average 90 stars, based on 1 article reviews
genetraffic bioinformatic software - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
microarray data analysis  (Genotypic Technology Pvt Ltd)
90
Genotypic Technology Pvt Ltd microarray data analysis
Microarray Data Analysis, supplied by Genotypic Technology Pvt Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/microarray+processing+and+data+analysis/10__1128_slash_mcb__00822___08-408-16-9
Average 90 stars, based on 1 article reviews
microarray data analysis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
microarray hybridization, washes, raw data pre-processing and normalization  (NimbleGen Systems GmbH)
90
NimbleGen Systems GmbH microarray hybridization, washes, raw data pre-processing and normalization
Microarray Hybridization, Washes, Raw Data Pre Processing And Normalization, supplied by NimbleGen Systems GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/microarray+hybridization++washes++raw+data+pre+processing+and+normalization/pmc03443086-192-0-11
Average 90 stars, based on 1 article reviews
microarray hybridization, washes, raw data pre-processing and normalization - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
microarray hybridization and analysis  (Cogenics Inc)
90
Cogenics Inc microarray hybridization and analysis
The allograft T Cell <t>microarray</t> data were analyzed by PCA using Partek Genomics Suite. 50% of the variation in samples was revealed in the first two principal components. The first principal component is represented by the X axis and the second principal component by the Y axis. Treatment type appeared to be major source of variation and is indicated by different colored ellipsoids. Green, untreated; Red, CsA only; and Blue, CsA plus peptide. The numbers next to each ellipsoid indicate the number of days post transplantation regardless of treatment type. The type of treatment appeared to be the most significant effect and the treatment time was another significant variable. Each treatment could be seen as distinct groups. Both the untreated (Green) and the cyclosporine treated (Red) samples seemed to form similar cluster shapes. Cyclosporine plus peptide (Blue) sample, on the other hand, was much more spread out. This could be due to another variable such as time after transplantation. Indeed, treatment time did appear to have some effect on the PCA since the ovoids representing 7 day-treatment samples were always to the left of the 1 or 3 days treatments.
Microarray Hybridization And Analysis, supplied by Cogenics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/microarray+hybridization+and+analysis/pmc02780702-203-1-8
Average 90 stars, based on 1 article reviews
microarray hybridization and analysis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
microarray experiments and statistical analysis  (Rosetta Inpharmatics)
90
Rosetta Inpharmatics microarray experiments and statistical analysis
The allograft T Cell <t>microarray</t> data were analyzed by PCA using Partek Genomics Suite. 50% of the variation in samples was revealed in the first two principal components. The first principal component is represented by the X axis and the second principal component by the Y axis. Treatment type appeared to be major source of variation and is indicated by different colored ellipsoids. Green, untreated; Red, CsA only; and Blue, CsA plus peptide. The numbers next to each ellipsoid indicate the number of days post transplantation regardless of treatment type. The type of treatment appeared to be the most significant effect and the treatment time was another significant variable. Each treatment could be seen as distinct groups. Both the untreated (Green) and the cyclosporine treated (Red) samples seemed to form similar cluster shapes. Cyclosporine plus peptide (Blue) sample, on the other hand, was much more spread out. This could be due to another variable such as time after transplantation. Indeed, treatment time did appear to have some effect on the PCA since the ovoids representing 7 day-treatment samples were always to the left of the 1 or 3 days treatments.
Microarray Experiments And Statistical Analysis, supplied by Rosetta Inpharmatics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/microarray+experiments+and+statistical+analysis/pm19998337-140-28-21
Average 90 stars, based on 1 article reviews
microarray experiments and statistical analysis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
extraction of polya-rna and subsequent microarray analysis  (Incyte corporation)
90
Incyte corporation extraction of polya-rna and subsequent microarray analysis
The allograft T Cell <t>microarray</t> data were analyzed by PCA using Partek Genomics Suite. 50% of the variation in samples was revealed in the first two principal components. The first principal component is represented by the X axis and the second principal component by the Y axis. Treatment type appeared to be major source of variation and is indicated by different colored ellipsoids. Green, untreated; Red, CsA only; and Blue, CsA plus peptide. The numbers next to each ellipsoid indicate the number of days post transplantation regardless of treatment type. The type of treatment appeared to be the most significant effect and the treatment time was another significant variable. Each treatment could be seen as distinct groups. Both the untreated (Green) and the cyclosporine treated (Red) samples seemed to form similar cluster shapes. Cyclosporine plus peptide (Blue) sample, on the other hand, was much more spread out. This could be due to another variable such as time after transplantation. Indeed, treatment time did appear to have some effect on the PCA since the ovoids representing 7 day-treatment samples were always to the left of the 1 or 3 days treatments.
Extraction Of Polya Rna And Subsequent Microarray Analysis, supplied by Incyte corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/extraction+of+polya+rna+and+subsequent+microarray+analysis/pmc04802869-124-11-4
Average 90 stars, based on 1 article reviews
extraction of polya-rna and subsequent microarray analysis - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
design and analysis of dna microarray investigations  (Verlag GmbH)
90
Verlag GmbH design and analysis of dna microarray investigations
The allograft T Cell <t>microarray</t> data were analyzed by PCA using Partek Genomics Suite. 50% of the variation in samples was revealed in the first two principal components. The first principal component is represented by the X axis and the second principal component by the Y axis. Treatment type appeared to be major source of variation and is indicated by different colored ellipsoids. Green, untreated; Red, CsA only; and Blue, CsA plus peptide. The numbers next to each ellipsoid indicate the number of days post transplantation regardless of treatment type. The type of treatment appeared to be the most significant effect and the treatment time was another significant variable. Each treatment could be seen as distinct groups. Both the untreated (Green) and the cyclosporine treated (Red) samples seemed to form similar cluster shapes. Cyclosporine plus peptide (Blue) sample, on the other hand, was much more spread out. This could be due to another variable such as time after transplantation. Indeed, treatment time did appear to have some effect on the PCA since the ovoids representing 7 day-treatment samples were always to the left of the 1 or 3 days treatments.
Design And Analysis Of Dna Microarray Investigations, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+processing+and+analysis/design+and+analysis+of+dna+microarray+investigations/10__1289_slash_ehp__112___1241912-70-7-28
Average 90 stars, based on 1 article reviews
design and analysis of dna microarray investigations - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


The allograft T Cell microarray data were analyzed by PCA using Partek Genomics Suite. 50% of the variation in samples was revealed in the first two principal components. The first principal component is represented by the X axis and the second principal component by the Y axis. Treatment type appeared to be major source of variation and is indicated by different colored ellipsoids. Green, untreated; Red, CsA only; and Blue, CsA plus peptide. The numbers next to each ellipsoid indicate the number of days post transplantation regardless of treatment type. The type of treatment appeared to be the most significant effect and the treatment time was another significant variable. Each treatment could be seen as distinct groups. Both the untreated (Green) and the cyclosporine treated (Red) samples seemed to form similar cluster shapes. Cyclosporine plus peptide (Blue) sample, on the other hand, was much more spread out. This could be due to another variable such as time after transplantation. Indeed, treatment time did appear to have some effect on the PCA since the ovoids representing 7 day-treatment samples were always to the left of the 1 or 3 days treatments.

Journal: PLoS ONE

Article Title: Down Regulation of Genes Involved in T Cell Polarity and Motility during the Induction of Heart Allograft Tolerance by Allochimeric MHC I

doi: 10.1371/journal.pone.0008020

Figure Lengend Snippet: The allograft T Cell microarray data were analyzed by PCA using Partek Genomics Suite. 50% of the variation in samples was revealed in the first two principal components. The first principal component is represented by the X axis and the second principal component by the Y axis. Treatment type appeared to be major source of variation and is indicated by different colored ellipsoids. Green, untreated; Red, CsA only; and Blue, CsA plus peptide. The numbers next to each ellipsoid indicate the number of days post transplantation regardless of treatment type. The type of treatment appeared to be the most significant effect and the treatment time was another significant variable. Each treatment could be seen as distinct groups. Both the untreated (Green) and the cyclosporine treated (Red) samples seemed to form similar cluster shapes. Cyclosporine plus peptide (Blue) sample, on the other hand, was much more spread out. This could be due to another variable such as time after transplantation. Indeed, treatment time did appear to have some effect on the PCA since the ovoids representing 7 day-treatment samples were always to the left of the 1 or 3 days treatments.

Article Snippet: The microarray hybridization and analysis were performed by Cogenics (Morrisville, NC) according to the manufacturer's protocol (Affymetrix, Santa Clara, CA).

Techniques: Microarray, Transplantation Assay